المؤلفون: Ailawadhi S; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA. ailawadhi.sikander@mayo.edu., Adu Y; Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA., Frank RD; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA., Das S; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Hodge DO; Department of Health Sciences Research/Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, USA., Fernandez A; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Flott C; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Elliott J; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Parrondo R; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Sher T; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Roy V; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Chanan-Khan AA; Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA.

المصدر: Blood cancer journal [Blood Cancer J] 2024 May 28; Vol. 14 (1), pp. 86. Date of Electronic Publication: 2024 May 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/epidemiology , Healthcare Disparities*, Humans ; Male ; Female ; Middle Aged ; Aged ; United States/epidemiology ; Adult ; Stem Cell Transplantation ; Hematopoietic Stem Cell Transplantation

المؤلفون: Abdallah N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Witzig TE; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Kumar SK; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Lacy MQ; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Hayman SR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Dispenzieri A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Roy V; Division of Hematology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA., Gertz MA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Bergsagel PL; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA., Rajkumar SV; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. rajkumar.vincent@mayo.edu.

المصدر: Leukemia [Leukemia] 2024 May; Vol. 38 (5), pp. 1169-1171. Date of Electronic Publication: 2024 Feb 28.

نوع المنشور: Clinical Trial, Phase III; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Letter; Journal Article

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/drug therapy, Humans ; Follow-Up Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Male ; Middle Aged ; Aged ; Prognosis ; Survival Rate

المؤلفون: Alhaj Moustafa M; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Parrondo R; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Abdulazeez MF; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Roy V; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Sher T; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Alegria VR; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Warsame RM; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Fonseca R; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA., Rasheed A; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Gonsalves WI; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kourelis T; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Buadi FK; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Dingli D; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Hayman SR; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Reeder CB; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA., Chanan-Khan AA; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida., Ailawadhi S; Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, Florida.

المصدر: Anti-cancer drugs [Anticancer Drugs] 2024 Jan 01; Vol. 35 (1), pp. 63-69. Date of Electronic Publication: 2023 Apr 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy, Humans ; Lenalidomide/therapeutic use ; Dexamethasone/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

المؤلفون: Yadav U; Division of Hematology, Mayo Clinic, Rochester, MN., Kumar SK; Division of Hematology, Mayo Clinic, Rochester, MN., Baughn LB; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN., Greipp P; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Ketterling R; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Jevremovic D; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN., Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN., Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN., Fonseca R; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ., Bergsagel PL; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ., Ailawadhi S; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL., Roy V; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL., Parrondo R; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL., Sher T; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL., Hayman SR; Division of Hematology, Mayo Clinic, Rochester, MN., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN., Leung N; Division of Hematology, Mayo Clinic, Rochester, MN.; Division of Nephrology, Mayo Clinic, Rochester, MN., Cook J; Division of Hematology, Mayo Clinic, Rochester, MN., Binder M; Division of Hematology, Mayo Clinic, Rochester, MN., Muchtar E; Division of Hematology, Mayo Clinic, Rochester, MN., Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN., Kourelis TV; Division of Hematology, Mayo Clinic, Rochester, MN., Go RS; Division of Hematology, Mayo Clinic, Rochester, MN., Lin Y; Division of Hematology, Mayo Clinic, Rochester, MN., Seth A; Division of Hematology, Mayo Clinic, Rochester, MN., Lester SC; Department of Radiation Oncology, Mayo Clinic, Rochester, MN., Breen WG; Department of Radiation Oncology, Mayo Clinic, Rochester, MN., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN., Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN., Gonsalves WI; Division of Hematology, Mayo Clinic, Rochester, MN.

المصدر: Blood [Blood] 2023 Nov 30; Vol. 142 (22), pp. 1871-1878.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Plasmacytoma*/genetics , Multiple Myeloma*/diagnosis , Multiple Myeloma*/genetics, Humans ; In Situ Hybridization, Fluorescence ; Chromosome Aberrations ; Prognosis ; Disease Progression

المؤلفون: Das S; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL 32224, USA., Ailawadhi S; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL 32224, USA., Sher T; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL 32224, USA., Roy V; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL 32224, USA., Fernandez A; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL 32224, USA., Parrondo RD; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL 32224, USA.; Mangurian Building, 3rd Floor, 4500 San Pablo Road S, Jacksonville, FL 32224, USA.

المصدر: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Oct 31; Vol. 30 (11), pp. 9627-9633. Date of Electronic Publication: 2023 Oct 31.

نوع المنشور: Case Reports

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Multiple Myeloma*/drug therapy , Receptors, Chimeric Antigen*/therapeutic use , Immunoglobulin Light-chain Amyloidosis*/complications , Immunoglobulin Light-chain Amyloidosis*/therapy , Kidney Diseases*/etiology, Humans ; Immunotherapy, Adoptive/adverse effects ; B-Cell Maturation Antigen/therapeutic use ; Cell- and Tissue-Based Therapy

المؤلفون: Yassine F; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Tsalantsanis A; Program for Comparative Effectiveness Research, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Roy V; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Zubair AC; Department of Pathology and Laboratory Medicine, Mayo Clinic, Jacksonville, FL, USA., Murthy HS; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Ayala E; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Iqbal M; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Sher T; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Ailawadhi S; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA., Parrondo RD; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA. Parrondo.Ricardo@mayo.edu.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2023 Oct; Vol. 58 (10), pp. 1130-1136. Date of Electronic Publication: 2023 Jul 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/pathology , Hematopoietic Stem Cell Transplantation*, Humans ; Retrospective Studies ; Transplantation, Autologous ; Autografts/pathology ; Hematopoietic Stem Cell Mobilization

المؤلفون: Visram A; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Hayman SR; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Dispenzieri A; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Kapoor P; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Lacy MQ; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Gertz MA; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Buadi FK; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Dingli D; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Warsame R; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Kourelis T; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Cook J; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Binder M; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Gonsalves W; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Muchtar E; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Leung N; Division of Nephrology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Roy V; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA., Rajkumar SV; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA., Kumar S; Division of Hematology, Mayo Clinic Rochester, Rochester, Minnesota, USA.

المصدر: American journal of hematology [Am J Hematol] 2023 Aug; Vol. 98 (8), pp. 1277-1285. Date of Electronic Publication: 2023 Jun 19.

نوع المنشور: Clinical Trial, Phase II; Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Hematopoietic Stem Cell Transplantation*, Humans ; Melphalan ; Transplantation, Autologous ; Transplantation Conditioning/methods ; Stem Cell Transplantation

المؤلفون: Dhakal B; BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee., Zhang MJ; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee., Burns LJ; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee., Tang X; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee., Meyer C; CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN., Mau LW; CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN., Nooka AK; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Stadtmauer E; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA., Micallef IN; Division of Hematology, Mayo Clinic, Rochester, MN., McGuirk J; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City., Costa L; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL., Juckett MB; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Shah N; Division of Hematology-Oncology; University of California San Francisco, San Francisco, CA., Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston., Usmani SZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York., Farag SS; Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL., Roy V; Blood and Marrow Transplant Program, Mayo Clinic, Jacksonville, FL., Bodiford A; US Medical Affairs - Transplantation, Sanofi, Bridgewater, NJ., Barnes YJ; US Medical Affairs - Hematology Oncology, Sanofi Specialty Care, Cambridge, MA., Drea EJ; US Medical - Oncology Medical Value and Outcomes, Sanofi Specialty Care, Cambridge, MA., Hari P; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee., Hamadani M; BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee. mhamadani@mcw.edu.

المصدر: Haematologica [Haematologica] 2023 Aug 01; Vol. 108 (8), pp. 2249-2254. Date of Electronic Publication: 2023 Aug 01.

نوع المنشور: Observational Study; Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Hematopoietic Stem Cell Transplantation* , Heterocyclic Compounds*, Humans ; Prospective Studies ; Hematopoietic Stem Cell Mobilization ; Granulocyte Colony-Stimulating Factor ; Benzylamines ; Transplantation, Autologous

المؤلفون: Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Roy V; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Murthy H; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Fischer D; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Mohty R; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Greathouse A; Department of Internal Medicine, Advanced Care at Home Program, Mayo Clinic, Jacksonville, FL, USA., Brown A; Department of Internal Medicine, Advanced Care at Home Program, Mayo Clinic, Jacksonville, FL, USA., Moreno K; Department of Internal Medicine, Advanced Care at Home Program, Mayo Clinic, Jacksonville, FL, USA., Godsey E; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Higginbotham JM; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Bartholomew A; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Jackson A; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Torres-Guzman RA; Department of Surgery, Mayo Clinic, Jacksonville, FL, USA., Forte AJ; Department of Surgery, Mayo Clinic, Jacksonville, FL, USA., Ailawadhi S; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Dronca R; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA., Maniaci M; Department of Internal Medicine, Advanced Care at Home Program, Mayo Clinic, Jacksonville, FL, USA.

المصدر: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2023 May 23; Vol. 16 (4), pp. 407-411. Date of Electronic Publication: 2023 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre Country of Publication: Saudi Arabia NLM ID: 101468532 Publication Model: Electronic Cited Medium: Internet ISSN: 2589-0646 (Electronic) Linking ISSN: 25890646 NLM ISO Abbreviation: Hematol Oncol Stem Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/methods , Multiple Myeloma*/therapy, Humans ; Female ; Adult ; Middle Aged ; Aged ; Treatment Outcome ; Transplantation, Autologous ; Melphalan ; Transplantation Conditioning/methods

المؤلفون: Ho M; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Zanwar S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Buadi FK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Ailawadhi S; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA., Larsen J; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA., Bergsagel L; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA., Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Chanan-Khan A; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA., Dingli D; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Fonseca R; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA., Gertz MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Gonsalves W; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Go RS; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Hayman S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Kourelis T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Lacy MQ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Leung N; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Lin Y; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Muchtar E; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Roy V; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA., Sher T; Division of Hematology, Mayo Clinic, Jacksonville, Florida, USA., Warsame R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Fonder A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Hobbs M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Hwa YL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Kyle RA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Kumar S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

المصدر: American journal of hematology [Am J Hematol] 2023 Jan; Vol. 98 (1), pp. 49-55. Date of Electronic Publication: 2022 Oct 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Immunoglobulin Light-chain Amyloidosis*/complications , Immunoglobulin Light-chain Amyloidosis*/therapy , Multiple Myeloma*/complications , Multiple Myeloma*/therapy, Humans ; COVID-19 Vaccines ; Risk Factors